Stavros Glentis

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

Florentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou et al. · Breast Cancer Research and Treatment · 2012 · 119 citations

Life Sciences, Genetics, Oncology +16

Perturbations of genes essential for Müllerian duct and Wölffian duct development in Mayer-Rokitansky-Küster-Hauser syndrome

Na Chen, Sen Zhao, Angad Jolly et al. · The American Journal of Human Genetics · 2021 · 89 citations · Full text

Life Sciences, Developmental Biology, Genetics +12

Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group

Michael C. Frühwald, Karolina Nemes, Heidrun Boztug et al. · Familial Cancer · 2021 · 57 citations · Full text

Life Sciences, Genetics, Oncology +17

Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group

Jette J. Bakhuizen, Helen Hanson, Karin van der Tuin et al. · Familial Cancer · 2021 · 54 citations · Full text

Life Sciences, Genetics, Oncology +16

Exome Sequencing in BRCA1- and BRCA2-Negative Greek Families Identifies MDM1 and NBEAL1 as Candidate Risk Genes for Hereditary Breast Cancer

Stavros Glentis, Alexandros C. Dimopoulos, Konstantinos Rouskas et al. · Frontiers in Genetics · 2019 · 33 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17